HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.45B |
| 2 |
Microsoft
MSFT
|
+$1.32B |
| 3 |
Amazon
AMZN
|
+$581M |
| 4 |
UnitedHealth
UNH
|
+$490M |
| 5 |
Tesla
TSLA
|
+$369M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$154M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$63.3M |
| 3 |
KAHC
KKR Acquisition Holdings I Corp.
KAHC
|
+$45.3M |
| 4 |
ASZ
Austerlitz Acquisition Corporation II
ASZ
|
+$34.9M |
| 5 |
Arch Capital
ACGL
|
+$34.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.54% |
| 2 | Financials | 13.56% |
| 3 | Healthcare | 13.03% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASTR
3001
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $27.8K | ﹤0.01% |
4,254
-448
| -10% | -$3.52K |
|
|
CTEV
3002
Claritev Corp
CTEV
$402M
| $27.4K | ﹤0.01% |
602
+289
| +92% | +$23.1K |
|
|
AUD
3003
DELISTED
Audacy, Inc.
AUD
| $26.6K | ﹤0.01% |
118,097
+84,549
| +252% | +$26.6K |
|
3004
Olema Pharmaceuticals
OLMA
$1.03B
| $26.1K | ﹤0.01% |
10,150
| – | – |
|
3005
Blend Labs
BLND
$424M
| $25.7K | ﹤0.01% |
18,939
+6,475
| +52% | +$11.6K |
|
3006
American Coastal Insurance
ACIC
$515M
| $24.7K | ﹤0.01% |
29,052
-3,810
| -12% | -$1.82K |
|
3007
NextCure
NXTC
$20.5M
| $24.1K | ﹤0.01% |
1,447
-74
| -5% | -$1.7K |
|
3008
CALL
Halliburton
HAL
$26.4B
| $23.6K | ﹤0.01% |
600
| – | – |
|
|
TUYA
3009
Tuya Inc
TUYA
$1.04B
| $22.7K | ﹤0.01% |
+11,868
| New | +$14.4K |
|
3010
Newegg Commerce
NEGG
$270M
| $21.8K | ﹤0.01% |
847
-7
| -0.8% | -$259 |
|
|
KORE
3011
DELISTED
KORE Group Holdings
KORE
| $21.4K | ﹤0.01% |
3,131
| – | – |
|
|
AMRS
3012
DELISTED
Amyris Inc.
AMRS
| $21K | ﹤0.01% |
13,748
-2,050
| -13% | -$4.58K |
|
|
FIRY
3013
Firy Inc
FIRY
$152M
| $20.6K | ﹤0.01% |
2,109
-497
| -19% | -$9.13K |
|
|
KRON
3014
DELISTED
Kronos Bio
KRON
| $20.1K | ﹤0.01% |
13,420
| – | – |
|
3015
Globalstar
GSAT
$10.3B
| $18.9K | ﹤0.01% |
+945
| New | +$24.8K |
|
3016
Aveanna Healthcare
AVAH
$2.11B
| $18.6K | ﹤0.01% |
26,978
| – | – |
|
3017
Momentus
MNTS
$85.1M
| $18.3K | ﹤0.01% |
2
| – | – |
|
|
GRTX
3018
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $17.9K | ﹤0.01% |
11,901
-434
| -4% | -$704 |
|
|
LLAP
3019
DELISTED
Terran Orbital Corporation
LLAP
| $17.8K | ﹤0.01% |
11,872
-4,263
| -26% | -$9.27K |
|
3020
Q32 Bio
QTTB
$462M
| $17.6K | ﹤0.01% |
863
| – | – |
|
3021
Gyre Therapeutics
GYRE
$648M
| $17.1K | ﹤0.01% |
4,337
| – | – |
|
|
TCRR
3022
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $16.9K | ﹤0.01% |
17,257
-1,544
| -8% | -$2.08K |
|
3023
Verastem
VSTM
$536M
| $15.9K | ﹤0.01% |
3,728
-40
| -1% | -$196 |
|
|
PVLA
3024
Palvella Therapeutics
PVLA
$2.15B
| $15.2K | ﹤0.01% |
202
-44
| -18% | -$3.54K |
|
3025
Assembly Biosciences
ASMB
$516M
| $14.3K | ﹤0.01% |
951
-56
| -6% | -$957 |
|
Similar funds
HSBC Holdings's Q4 2022 Portfolio in Review
As of Q4 2022, HSBC Holdings held 3,337 positions worth $87B, up 42% from $61.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
HSBC Holdings deployed $22.5B of net new capital in Q4 2022, opening 445 new positions and adding to 1,625 existing holdings. Its largest new stake was Bread Financial: 1,948,144 shares worth $72.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Pinduoduo, an estimated $154M trimmed.
- HSBC Holdings's largest Q4 2022 buy was Bread Financial: 1,948,144 shares worth $72.6M.
- HSBC Holdings added most to Apple in Q4 2022, an estimated $1.45B increase.
- HSBC Holdings's biggest Q4 2022 reduction was Pinduoduo, cutting an estimated $154M.
- HSBC Holdings fully exited Twitter, Inc. in Q4 2022, selling an estimated $63.3M.
- HSBC Holdings's ten largest holdings make up 19% of its $87B portfolio in Q4 2022.
- HSBC Holdings opened 445 new positions and closed 298 in Q4 2022.
- HSBC Holdings's portfolio value rose 42% quarter-over-quarter to $87B.
Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.